15 high-cost drugs, including Ozempic, get major Medicare price reductions in latest negotiation round
The cuts stem from the Inflation Reduction Act, not Trump’s “most favored nation” approach, and apply to what Medicare pays drugmakers.
A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare.
What did you think of this news? Leave a comment below and/or share it on your social media. This way, we can inform more people about the hottest things in technology, science, innovation, and gaming!
This news was originally published in:
Original source
